Comparative chronic toxicity of imidacloprid, clothianidin, and thiamethoxam toChironomus dilutusand estimation of toxic equivalency factors

2016 ◽  
Vol 36 (2) ◽  
pp. 372-382 ◽  
Author(s):  
Michael C. Cavallaro ◽  
Christy A. Morrissey ◽  
John V. Headley ◽  
Kerry M. Peru ◽  
Karsten Liber

1996 ◽  
Vol 42 (1-4) ◽  
pp. 401
Author(s):  
D.E. Tillitt ◽  
M. Tysklind ◽  
L. Eriksson ◽  
K. Lundgren ◽  
C. Rappe


1994 ◽  
Vol 40 (7) ◽  
pp. 1409-1415 ◽  
Author(s):  
S Skerfving ◽  
B G Svensson ◽  
L Asplund ◽  
L Hagmar

Abstract There are 209 congeners of polychlorinated biphenyls (PCBs), the metabolism and toxicity of which vary by congeners. Use of PCBs is now restricted, but environmental contamination and human exposure persist. Analysis for "total PCBs" in biological samples gives limited information; congener-specific analysis is far more informative, but more complicated. Concentrations of congeners in serum/plasma, adipose tissue, or milk are useful biomarkers of exposure. Lipids may contain similar concentrations and congener patterns, but these vary between exposures and are different from those of the corresponding exposure mixtures; hence, analysis of lipids cannot be used to identify the original exposure. Some non- and mono-ortho congeners may attain a coplanar conformation, which renders them capable of a dioxin-like action. Toxic equivalency factors (TEFs) have been used to sum that risk as toxic equivalents (TEQs), which are considerably different from congener concentrations. No reliable data have been developed on the relationship between concentrations of "total PCBs" or congeners in biological samples and effects of PCBs on human health, mainly because of the various analytical procedures involved and confounding exposures.



1995 ◽  
Vol 14 (5) ◽  
pp. 861-871 ◽  
Author(s):  
John L. Newsted ◽  
Paul D. Jones ◽  
John P. Giesy ◽  
Robert A. Crawford ◽  
Gerald T. Ankley ◽  
...  






2021 ◽  
Author(s):  
Eric Paul Buan

An enzyme-linked immunosorbent assay (ELISA) was tested for its ability to screen for PCDD/F in soils and sediments at 50, 1000 and 10,000 picograms toxic equivalents per gram of soil pgTEQ g-₁ (n=48, r²=0.994, slope=0.94). These results relied on two concepts developed in this thesis. The first, a congener correction factor, corrects ELISA results for differences in how ELISA and GC-HRMS calculate the dioxin content of a sample. The congener correction factor increased the correlation between ELISA and GC-HRMS TEQ values calculated using World Health Organization (WHO) toxic equivalency factors (TEF) from 83% to 94%. The correlation between ELISA and GC-HRMS TEQ values calculated using North Atlantic Treaty Organization (NATO) TEF remained strong when the correction factor was applied, falling from 102% to 94%. The second concept, a sample algorithm allows ELIAS to efficiently measure unknown PCDD/F concentrations between 30 and 10,5000 pgTEQ g-¹. The algorithm successfully placed 24 of 28 samples into their correct concentration ranges in a maximum of two ELISA each. A cost analysis of using the algorithm predicted that ELISA can screen samples three times faster than GC-HRMS while at a 60% reduction in operating cost. The success of ELISA in conjunction with its time and cost savings indicate that it can replace GC-HRMS in situations where the high precision of GC-HRMS is not required.



Chemosphere ◽  
1994 ◽  
Vol 28 (6) ◽  
pp. 1049-1067 ◽  
Author(s):  
UG Ahlborg ◽  
GC Becking ◽  
LS Birnbaum ◽  
A Brouwer ◽  
HJGM Derks ◽  
...  


1994 ◽  
Vol 1 (2) ◽  
pp. 67-68 ◽  
Author(s):  
Ulf G. Ahlborg ◽  
Annika Hanberg


Sign in / Sign up

Export Citation Format

Share Document